Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,545 USD | -2,51% | -4,53% | -20,32% |
Omzet 2024 * | 538K 502K | Omzet 2025 * | 675K 630K | Marktkapitalisatie | 22,98 mln. 21,44 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -37 mln. -34,53 mln. | Nettowinst (verlies) 2025 * | -48 mln. -44,79 mln. | EV/omzet 2024 * | 42,8 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 34 x |
K/w-verhouding 2024 * |
-0,8
x | K/w-verhouding 2025 * |
-1,01
x | Werknemers | 29 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,25% |
Recentste transcriptie over Oncternal Therapeutics, Inc.
1 dag | -2,51% | ||
1 week | -4,53% | ||
Lopende maand | -5,06% | ||
1 maand | +3,95% | ||
3 maanden | -4,31% | ||
6 maanden | +35,63% | ||
Lopend jaar | -20,32% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Breitmeyer
FOU | Founder | 70 | 01-01-97 |
Richard Vincent
DFI | Director of Finance/CFO | 61 | 01-04-17 |
Salim Yazji
CTO | Chief Tech/Sci/R&D Officer | 55 | 17-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hale
FOU | Founder | 75 | 01-01-97 |
Dan Kisner
BRD | Director/Board Member | 77 | 07-06-19 |
Rosemary Mazanet
BRD | Director/Board Member | 67 | 27-01-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 8,545 | -2,51% | 1 600 |
23-04-24 | 8,765 | +2,51% | 955 |
22-04-24 | 8,55 | -3,50% | 1 657 |
19-04-24 | 8,86 | +3,02% | 4 539 |
18-04-24 | 8,6 | -3,91% | 2 821 |
uitgestelde koers Nasdaq, 24 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,32% | 22,98 mln. | |
+4,09% | 43,84 mld. | |
+47,81% | 41,25 mld. | |
+9,45% | 41,68 mld. | |
-10,92% | 27,04 mld. | |
+9,32% | 25,53 mld. | |
-24,87% | 18,18 mld. | |
+29,70% | 12,29 mld. | |
+1,28% | 12,29 mld. | |
+7,78% | 11,15 mld. |